Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Yangambin is a selective antagonist of the cardiovascular effects of platelet activating factor (PAF); it has hypotensive effect, which is probably due to a peripheral vasodilatation that involves, at least, the inhibition the Ca2+ influx through voltage-gated Ca2+ channels. Yangambin also has central nervous system activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 287.00 | |
5 mg | In stock | $ 691.00 | |
10 mg | In stock | $ 985.00 | |
25 mg | In stock | $ 1,490.00 | |
50 mg | In stock | $ 1,960.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 856.00 |
Description | Yangambin is a selective antagonist of the cardiovascular effects of platelet activating factor (PAF); it has hypotensive effect, which is probably due to a peripheral vasodilatation that involves, at least, the inhibition the Ca2+ influx through voltage-gated Ca2+ channels. Yangambin also has central nervous system activity. |
Source |
Molecular Weight | 446.49 |
Formula | C24H30O8 |
CAS No. | 13060-14-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/ml (134.38 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Yangambin 13060-14-5 GPCR/G Protein Membrane transporter/Ion channel Metabolism PAFR Calcium Channel inhibit Ca channels Ca2+ channels Inhibitor inhibitor